Anna Means
Assistant Professor
Last active: 1/6/2017

  1. Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation. Drosos Y, Neale G, Ye J, Paul L, Kuliyev E, Maitra A, Means AL, Washington MK, Rehg J, Finkelstein DB, Sosa-Pineda B (2016) Neoplasia 18(3): 172-84
    › Primary publication · 26992918 (PubMed) · PMC4796801 (PubMed Central)
  2. Expression of CD24, a Stem Cell Marker, in Pancreatic and Small Intestinal Neuroendocrine Tumors. Salaria S, Means A, Revetta F, Idrees K, Liu E, Shi C (2015) Am J Clin Pathol 144(4): 642-8
    › Primary publication · 26386086 (PubMed) · PMC4576728 (PubMed Central)
  3. Loss of HNF6 expression correlates with human pancreatic cancer progression. Pekala KR, Ma X, Kropp PA, Petersen CP, Hudgens CW, Chung CH, Shi C, Merchant NB, Maitra A, Means AL, Gannon MA (2014) Lab Invest 94(5): 517-27
    › Primary publication · 24638272 (PubMed) · PMC4068339 (PubMed Central)
  4. Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia. Ray KC, Moss ME, Franklin JL, Weaver CJ, Higginbotham J, Song Y, Revetta FL, Blaine SA, Bridges LR, Guess KE, Coffey RJ, Crawford HC, Washington MK, Means AL (2014) Oncogene 33(7): 823-31
    › Primary publication · 23376846 (PubMed) · PMC3929321 (PubMed Central)
  5. Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction. Shi C, Washington MK, Chaturvedi R, Drosos Y, Revetta FL, Weaver CJ, Buzhardt E, Yull FE, Blackwell TS, Sosa-Pineda B, Whitehead RH, Beauchamp RD, Wilson KT, Means AL (2014) Lab Invest 94(4): 409-21
    › Primary publication · 24535260 (PubMed) · PMC3992484 (PubMed Central)
  6. Pancreatic stellate cells: small cells with a big role in tissue homeostasis. Means AL (2013) Lab Invest 93(1): 4-7
    › Primary publication · 23269285 (PubMed)
  7. Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma. Al-Greene NT, Means AL, Lu P, Jiang A, Schmidt CR, Chakravarthy AB, Merchant NB, Washington MK, Zhang B, Shyr Y, Deane NG, Beauchamp RD (2013) PLoS One 8(7): e69660
    › Primary publication · 23922772 (PubMed) · PMC3726759 (PubMed Central)
  8. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Powell AE, Wang Y, Li Y, Poulin EJ, Means AL, Washington MK, Higginbotham JN, Juchheim A, Prasad N, Levy SE, Guo Y, Shyr Y, Aronow BJ, Haigis KM, Franklin JL, Coffey RJ (2012) Cell 149(1): 146-58
    › Primary publication · 22464327 (PubMed) · PMC3563328 (PubMed Central)
  9. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin. Freeman TJ, Smith JJ, Chen X, Washington MK, Roland JT, Means AL, Eschrich SA, Yeatman TJ, Deane NG, Beauchamp RD (2012) Gastroenterology 142(3): 562-571.e2
    › Primary publication · 22115830 (PubMed) · PMC3343368 (PubMed Central)
  10. Genetic interactions between hepatocyte nuclear factor-6 and Notch signaling regulate mouse intrahepatic bile duct development in vivo. Vanderpool C, Sparks EE, Huppert KA, Gannon M, Means AL, Huppert SS (2012) Hepatology 55(1): 233-43
    › Primary publication · 21898486 (PubMed) · PMC3235248 (PubMed Central)